Luxfer Holdings PLC
Rank #316ValueLXFR · NYSE · Industrials
Luxfer Holdings PLC (LXFR) — Rank #316 by gross profitability (GP/assets 0.23) · ROE 3.4% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0001096056 · all metrics point-in-time as of the filing date.
About
Luxfer Holdings PLC, together with its subsidiaries, develops and manufactures high-performance materials, components, and high-pressure gas containment devices.
Show moreShow less
The company operates through two segments: Gas Cylinders and Elektron. The Gas Cylinders segment manufactures and markets specialized highly engineered containment solutions using aluminum alloys and carbon composite technologies. It offers carbon composite high-pressure, aerospace and aviation, space-related, aluminum and composite medical gas, and specialty aluminum cylinders used for emergency response, healthcare, alternative fuel transportation, aerospace comprising commercial aviation, defense, and space markets. The Elektron segment focuses on specialty materials based primarily on magnesium and zirconium. This segment offers advanced lightweight magnesium alloys; magnesium powders for use in countermeasure flares, defense applications, infrared decoys, and heater meals; and zirconium-based chemicals and oxides used as catalysts converters, industrial catalysis, advanced ceramics, specialty glass, fuel cell components, pharmaceuticals, and other performance-critical applications. The company operates in the United States, the United Kingdom, Japan, Canada, Germany, rest of Europe, the Asia Pacific, and the rest of the world.
Luxfer Holdings PLC was founded in 1898 and is based in Riverside, California.
- Industry
- Specialty Industrial Machinery
- Sector
- Industrials
- State
- X0
- Filer Category
- Accelerated filer
- Fiscal Year End
- December 31
- Website
- luxfer.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-24 | 2024-12-31filed 2025-02-25 | 2023-12-31filed 2024-02-27 | 2022-12-31filed 2023-03-01 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 9.9 | 10.1 | 12.7 | 13.6 |
| Stock-based compensation | 3.6 | 3.5 | 2.8 | 2.5 |
| Change in inventory | 6.7 | 4.1 | (16.6) | 25.0 |
| Change in payables | (5.7) | 4.8 | (19.0) | 21.3 |
| Operating cash flow | 34.0 | 51.1 | 26.3 | 15.9 |
| Investing | ||||
| Capital expenditures | 7.8 | 10.3 | 9.4 | 8.3 |
| Acquisitions, net of cash | — | — | 0.0 | 0.0 |
| Investing cash flow | (5.1) | (3.4) | (9.5) | (5.7) |
| Financing | ||||
| Debt issued | 36.7 | — | — | — |
| Debt repaid | 26.7 | — | — | — |
| Share repurchases | 3.1 | 2.3 | 2.7 | 11.1 |
| Dividends paid | 13.9 | 14.0 | 14.0 | 14.2 |
| Financing cash flow | (25.0) | (44.0) | (27.5) | (2.0) |
| Summary | ||||
| Free cash flow | 26.2 | 40.8 | 16.9 | 7.6 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?